Horizons Ventures

Spiderwort is a company focused on developing innovative biomaterials for regenerative medicine, aiming to repair and regenerate human tissues. Founded in 2015 and based in Ottawa, Ontario, the company utilizes plant-derived cellulose to create various scaffold architectures, including powders, gels, membranes, and pastes. Currently in the pre-clinical stage, Spiderwort's novel biomaterials have shown promising results in terms of biocompatibility and their ability to induce angiogenesis, the generation of new blood vessels within the scaffolds. This approach seeks to advance applications in the healthcare industry, particularly for spinal cord injury repair and soft tissue regeneration, by utilizing plant-based materials rather than traditional synthetic substances.

Spiderwort is a company focused on developing innovative biomaterials for regenerative medicine, aiming to repair and regenerate human tissues. Founded in 2015 and based in Ottawa, Ontario, the company utilizes plant-derived cellulose to create various scaffold architectures, including powders, gels, membranes, and pastes. Currently in the pre-clinical stage, Spiderwort's novel biomaterials have shown promising results in terms of biocompatibility and their ability to induce angiogenesis, the generation of new blood vessels within the scaffolds. This approach seeks to advance applications in the healthcare industry, particularly for spinal cord injury repair and soft tissue regeneration, by utilizing plant-based materials rather than traditional synthetic substances.